Chargement en cours...
Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?
The SARS-CoV-2 has infected more than 3 million people and caused more than 240,000 death globally. Among the COVID-19 patients, the prevalence of people with other chronic diseases, such as diabetes, high blood pressure, and coronary heart disease is much higher than others. More strikingly, the su...
Enregistré dans:
| Publié dans: | Med Drug Discov |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Published by Elsevier B.V.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7266598/ https://ncbi.nlm.nih.gov/pubmed/32551437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medidd.2020.100048 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|